Johnson & Johnson Pharmaceutical Research & Development, LLC FDA Record
- Latest inspection NAI · Jun 30, 2011
- Last warning letter 2009
Johnson & Johnson Pharmaceutical Research & Development, LLC has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Johnson & Johnson Pharmaceutical Research & Development, LLC, the most recent on Aug 10, 2009.
- Latest recall
- Z-0284-2027 · Sep 23, 2026 · filed under Ethicon
- Latest inspection
- Jun 30, 2011 · NAI
Newer recall under related name Ethicon: Sep 23, 2026, Z-0284-2027.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Johnson & Johnson Pharmaceutical Research & Development, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Johnson & Johnson Pharmaceutical Research & Development, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Johnson & Johnson Pharmaceutical Research & Development, LLC FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Aug 10, 2009 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 30, 2011 | Raritan, NJ | Drugs | No Action Indicated (NAI) | 3006192174 |
| Apr 12, 2011 | Raritan, NJ | Drugs | No Action Indicated (NAI) | 3006192174 |
| Aug 20, 2010 | Raritan, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006192174 |
| Apr 14, 2009 | Raritan, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006192174 |
| Mar 27, 2009 | Raritan, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006192174 |
| Mar 24, 2009 | Raritan, NJ | Drugs | No Action Indicated (NAI) | 3006192174 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Johnson & Johnson Pharmaceutical Research & Development, LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006192174 | Raritan, NJ | 6 | Jun 30, 2011 |
Johnson & Johnson Pharmaceutical Research & Development, LLC and the FDA: common questions
Has Johnson & Johnson Pharmaceutical Research & Development, LLC received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Johnson & Johnson Pharmaceutical Research & Development, LLC. The most recent is dated Aug 10, 2009.
Has Johnson & Johnson Pharmaceutical Research & Development, LLC received an FDA Form 483?
FDA has not published a Form 483 for "Johnson & Johnson Pharmaceutical Research & Development, LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Johnson & Johnson Pharmaceutical Research & Development, LLC?
The most recent FDA inspection on file ended Jun 30, 2011 at Raritan, NJ and was classified NAI. FDA has 6 inspections of Johnson & Johnson Pharmaceutical Research & Development, LLC on file.
Need more than this page shows? Ask about Johnson & Johnson Pharmaceutical Research & Development, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.